EUVIMEDEUVIMED entdecken
Open Access

Clinical and Functional Characterization of PDE1A as a Wnt/β-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer

Gwan Hee Han, Hee Yun, Joon-Yong Chung, Jae-Hoon Kim, Hanbyoul Cho

Oncology Research · 2026

DOI: 10.32604/or.2025.072105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Gwan Hee Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, 84 Heukseok-ro, Dongjak-gu, Seoul, 06974, Republic of Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Biomarkers, Tumor, Cyclic Nucleotide Phosphodiesterases, Type 1. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Phosphodiesterase 1A (PDE1A) regulates intracellular cyclic nucleotide signaling and has been implicated in tumor progression, but its clinical relevance and functional role in epithelial ovarian cancer (EOC), particularly in relation to the response to platinum remain unclear. This study aimed to evaluate the clinical significance of PDE1A in EOG and to clarify its functional role in tumor progression and response to platinum-based chemotherapy.

Methods

PDE1A mRNA and protein levels were analyzed using public databases, RNA sequencing, and immunohistochemistry. Correlations between PDE1A expression, clinicopathological features, and prognosis were assessed. Functional roles were investigated in ovarian cancer cell lines.

Results

PDE1A was significantly overexpressed in EOC tissues compared with that in normal ovarian epithelial tissues. Overexpression correlated with advanced International Federation of Gynecology and Obstetrics (FIGO) stage, poor tumor grade, and reduced response to platinum-based chemotherapy. High PDE1A levels were linked to worse disease-free survival and overall survival, and multivariate analysis confirmed PDE1A as an independent prognostic factor. To elucidate its functional role, we performed in vitro experiments showing that PDE1A knockdown suppressed cell proliferation and colony formation, induced G1 arrest, and downregulated β-catenin signaling with reduced cyclin D1 and c-Myc expression. Notably, these inhibitory effects were partially rescued by lithium chloride (LiCl), a Wingless-related integration site (Wnt)/β-catenin activator.

Conclusions

In conclusion, our findings identify PDE1A as a Wnt/β-catenin-linked biomarker of tumor progression and platinum resistance in EOC and provide a biological rationale for further investigation of PDE1A-targeted strategies in preclinical models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCarcinoma, Ovarian EpithelialBiomarkers, TumorCyclic Nucleotide Phosphodiesterases, Type 1Drug Resistance, NeoplasmWnt Signaling Pathwaybeta CateninHumansFemalePrognosisDisease ProgressionCell Line, TumorCell ProliferationMiddle AgedGene Expression Regulation, NeoplasticPlatinum

Stichwörter der Autor:innen

Beta-cateninbiomarkerepithelial ovarian cancerphosphodiesterase 1Awingless-related integration site (Wnt)

Substanzen

Biomarkers, TumorCyclic Nucleotide Phosphodiesterases, Type 1beta CateninCTNNB1 protein, humanPlatinum

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Chung-Ang University College of Medicine, 84 Heukseok-ro, Dongjak-gu, Seoul, 06974, Republic of Korea.
  • Department of Obstetrics and Gynecology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, 06973, Republic of Korea.
  • Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Gangnam-gu, Seoul, 06299, Republic of Korea.
  • Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, 06299, Republic of Korea.
  • Institute of Women's Life Medical Science, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.

Zitieren

APA

Han, G. H., Yun, H., Chung, J. Y., Kim, J. H., & Cho, H. (2026). Clinical and Functional Characterization of PDE1A as a Wnt/β-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer. Oncology Research. https://doi.org/10.32604/or.2025.072105

Vancouver

Han GH, Yun H, Chung JY, Kim JH, Cho H. Clinical and Functional Characterization of PDE1A as a Wnt/β-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer. Oncology Research. 2026. doi:10.32604/or.2025.072105

BibTeX
@article{Han2026,
  author = {Han, Gwan Hee and Yun, Hee and Chung, Joon-Yong and Kim, Jae-Hoon and Cho, Hanbyoul},
  title = {Clinical and Functional Characterization of PDE1A as a Wnt/β-Catenin-Linked Biomarker of Progression and Platinum Resistance in Epithelial Ovarian Cancer},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2025.072105}
}
Kostenlos starten →